AA
ZBH icon

ALPS Advisors’s Zimmer Biomet ZBH Stock Holding History

ALPS Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,350
Closed -$354K – 1134
2024
Q4 		$354K Hold
3,350
– – ﹤0.01% 783
2024
Q3 		$362K Buy
+3,350
New +$366K ﹤0.01% 805
2020
Q3 		– Sell
-2,418
Closed -$280K – 951
2020
Q2 		$280K Sell
2,418
-269
-10% -$31K ﹤0.01% 579
2020
Q1 		$264K Sell
2,687
-1,900
-41% -$249K ﹤0.01% 530
2019
Q4 		$667K Sell
4,587
-324
-7% -$44.7K 0.01% 469
2019
Q3 		$655K Sell
4,911
-2,068
-30% -$267K 0.01% 432
2019
Q2 		$798K Buy
6,979
+108
+2% +$12.6K 0.01% 377
2019
Q1 		$852K Buy
6,871
+3,222
+88% +$366K 0.01% 364
2018
Q4 		$367K Sell
3,649
-151
-4% -$17K ﹤0.01% 668
2018
Q3 		$485K Buy
+3,800
New +$452K ﹤0.01% 670

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ALPS Advisors's ZBH Position: Q1 2025 in Review

ALPS Advisors sold out of Zimmer Biomet (ZBH) in Q1 2025, closing a stake of 3,350 shares — an estimated $354K sold.

ALPS Advisors first reported a position in ZBH in Q3 2018 and held it in 10 quarters. The position peaked at $852K in Q1 2019. 1,000 funds tracked by Wall St. Rank hold ZBH as of Q1 2025.

  • ALPS Advisors reported no remaining Zimmer Biomet position as of Q1 2025 after selling out during the quarter.
  • ALPS Advisors sold 3,350 Zimmer Biomet shares in Q1 2025, an estimated $354K.
  • ALPS Advisors first reported a position in Zimmer Biomet in Q3 2018 and held it in 10 quarters.
  • ALPS Advisors's Zimmer Biomet position peaked at $852K in Q1 2019.
  • 1,000 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2025.

Based on ALPS Advisors's 13F filing for Q1 2025, filed 30 Apr 2025.